Name: Tramadol Use and Renal Disease in Garoua (Cameroon) (en Inglés)
Price: 306658.00 COP
Availability: InStock
Author: Ewodo Touna, Hilaire Dominique ; Ashuntantang, Gloria ; Essi, Marie José
ISBN: 9786205305744

portada Tramadol Use and Renal Disease in Garoua (Cameroon) (en Inglés)

Formato

Libro Físico

Autor

Gloria Ashuntantang

Hilaire Dominique Ewodo Touna

Marie José Essi

Editorial

Our Knowledge Publishing

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 0.5 cm

Peso

0.14 kg.

ISBN13

9786205305744

Categorías

Cuestiones generales de la medicina

Tramadol Use and Renal Disease in Garoua (Cameroon) (en Inglés)

Gloria Ashuntantang (Autor) · Hilaire Dominique Ewodo Touna (Autor) · Marie José Essi (Autor) · Our Knowledge Publishing · Tapa Blanda

Libro Nuevo

$ 306.658

$ 471.782

Ahorras: $ 165.124

35% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 26 de Julio y el Martes 06 de Agosto.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "Tramadol Use and Renal Disease in Garoua (Cameroon) (en Inglés)"

Kidney disease is a public health problem because of: Its ever-increasing incidence The high associated mortality and the cost of its management. It affects 10% of adults worldwide in its chronic form. Hypertension, diabetes, chronic infections are the main risk factors but also nephrotoxic substances. Which represents 5% of the causes. Among these nephrotoxic substances: analgesics occupy a proportion of 20%, but also Opiates (heroin and cocaine). However, in sub-Saharan Africa, and in Cameroon in particular, tramadol, a second-tier analgesic derived from opioids, used clinically for the treatment of pain, has been increasingly found in illicit channels and abused since 2003. In addition, the increase in the number of patients with end-stage renal disease, which rose from 30 in 2000 to 497 in 2012 in Cameroon, has led to the question of whether chronic users of tramadol are at risk of developing renal disease.